Cansino Biologics Inc.
Clinical trials sponsored by Cansino Biologics Inc., explained in plain language.
A vaccine company developing and manufacturing vaccines, including for COVID-19.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New 24-Strain pneumonia vaccine enters human trials
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine (PCV24) designed to protect against 24 types of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. The trial includes 854 healthy people aged 2 months and older, split into two phases to check safety and immune respons…
Phase: PHASE1, PHASE2 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 07, 2026 00:00 UTC
-
One shot to rule them all? new combo vaccine trial for kids begins
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial is testing a new vaccine that combines protection against several serious childhood diseases: diphtheria, tetanus, whooping cough, meningitis, and Hib. The study involves 260 children aged 2 months to 6 years to check the vaccine's safety and immune respons…
Phase: PHASE1 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:07 UTC